Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.53 EUR | +1.89% | +2.65% | -20.04% |
09-09 | Nerves of steel needed in the current environment | |
09-05 | ARCELORMITTAL : Jefferies reiterates its Buy rating | ZD |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 70.62B | 53.27B | 76.57B | 79.84B | 68.28B | |||||
Total Revenues | 70.62B | 53.27B | 76.57B | 79.84B | 68.28B | |||||
Cost of Goods Sold, Total | 66.16B | 48.42B | 57.43B | 65.83B | 62.5B | |||||
Gross Profit | 4.46B | 4.84B | 19.14B | 14.02B | 5.78B | |||||
Selling General & Admin Expenses, Total | 2.46B | 2.1B | 2.15B | 2.02B | 2.34B | |||||
R&D Expenses | 301M | 245M | 270M | 286M | 299M | |||||
Impairment of Oil, Gas & Mineral Properties - (IS) | - | - | - | - | - | |||||
Other Operating Expenses, Total | 2.76B | 2.35B | 2.42B | 2.31B | 2.64B | |||||
Operating Income | 1.7B | 2.5B | 16.72B | 11.71B | 3.14B | |||||
Interest Expense, Total | -695M | -477M | -357M | -401M | -715M | |||||
Interest And Investment Income | 88M | 56M | 79M | 188M | 570M | |||||
Net Interest Expenses | -607M | -421M | -278M | -213M | -145M | |||||
Income (Loss) On Equity Invest. | 347M | 234M | 2.2B | 1.32B | 1.18B | |||||
Currency Exchange Gains (Loss) | 4M | 107M | -155M | 191M | -48M | |||||
Other Non Operating Income (Expenses) | -573M | -319M | -204M | -261M | -423M | |||||
EBT, Excl. Unusual Items | 866M | 2.1B | 18.28B | 12.74B | 3.71B | |||||
Restructuring Charges | - | -342M | - | -55M | - | |||||
Merger & Related Restructuring Charges | - | - | - | -7M | -4M | |||||
Impairment of Goodwill | - | - | - | - | -194M | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | -1.4B | |||||
Asset Writedown | -2.73B | -371M | 218M | -1.53B | -844M | |||||
Legal Settlements | - | - | -163M | - | - | |||||
Other Unusual Items | -71M | -298M | -314M | 100M | - | |||||
EBT, Incl. Unusual Items | -1.93B | 1.09B | 18.02B | 11.26B | 1.26B | |||||
Income Tax Expense | 459M | 1.67B | 2.46B | 1.72B | 238M | |||||
Earnings From Continuing Operations | -2.39B | -578M | 15.56B | 9.54B | 1.02B | |||||
Net Income to Company | -2.39B | -578M | 15.56B | 9.54B | 1.02B | |||||
Minority Interest | -63M | -155M | -609M | -236M | -103M | |||||
Net Income - (IS) | -2.45B | -733M | 14.96B | 9.3B | 919M | |||||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||||
Net Income to Common Incl Extra Items | -2.45B | -733M | 14.96B | 9.3B | 919M | |||||
Net Income to Common Excl. Extra Items | -2.45B | -733M | 14.96B | 9.3B | 919M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -2.42 | -0.64 | 13.53 | 10.21 | 1.09 | |||||
Basic EPS - Continuing Operations | -2.42 | -0.64 | 13.53 | 10.21 | 1.09 | |||||
Basic Weighted Average Shares Outstanding | 1.01B | 1.14B | 1.1B | 911M | 842M | |||||
Net EPS - Diluted | -2.42 | -0.64 | 13.49 | 10.18 | 1.09 | |||||
Diluted EPS - Continuing Operations | -2.42 | -0.64 | 13.49 | 10.18 | 1.09 | |||||
Diluted Weighted Average Shares Outstanding | 1.01B | 1.14B | 1.11B | 914M | 845M | |||||
Normalized Basic EPS | 0.47 | 1.01 | 9.79 | 8.48 | 2.63 | |||||
Normalized Diluted EPS | 0.47 | 1.01 | 9.76 | 8.46 | 2.62 | |||||
Dividend Per Share | - | 0.3 | 0.38 | 0.44 | 0.5 | |||||
Payout Ratio | -8.27 | - | 2.09 | 3.57 | 40.15 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 4.42B | 5.25B | 19.05B | 14.1B | 5.58B | |||||
EBITA | 1.79B | 2.58B | 16.81B | 11.8B | 3.26B | |||||
EBIT | 1.7B | 2.5B | 16.72B | 11.71B | 3.14B | |||||
EBITDAR | 4.72B | 5.51B | 19.28B | 14.35B | 5.82B | |||||
Effective Tax Rate - (Ratio) | -23.76 | 153.12 | 13.65 | 15.26 | 18.89 | |||||
Total Current Taxes | 786M | 839M | 2.95B | 2.08B | 1.01B | |||||
Total Deferred Taxes | -327M | 827M | -493M | -363M | -770M | |||||
Normalized Net Income | 478M | 1.16B | 10.82B | 7.73B | 2.21B | |||||
Interest on Long-Term Debt | 98M | 66M | 33M | 34M | 55M | |||||
Non-Cash Pension Expense | 90M | 96M | 86M | 31M | 85M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 301M | 245M | 270M | 286M | 299M | |||||
Net Rental Expense, Total | 298M | 268M | 230M | 254M | 242M | |||||
Imputed Operating Lease Interest Expense | 124M | 76.71M | 63.4M | 81.28M | 124M | |||||
Imputed Operating Lease Depreciation | 174M | 191M | 167M | 173M | 118M | |||||
Stock-Based Comp., Other (Total) | - | 30M | 35M | 38M | 39M | |||||
Total Stock-Based Compensation | - | 30M | 35M | 38M | 39M |